MedPath

Nasathera CPM

Brand Name: Nasathera CPM

Generic Name: Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate

Active
Registration Number

DR-XY36065

Dosage Form

Syrup

Issuance Date

May 31, 2024

Expiry Date

June 25, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength12.5mg/2mg/5mL
PackagingAmber glass bottle x 60mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Nasal Decongestant / Antihistamine
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Phenylpropanolamine HydrochlorideActive
Chlorphenamine MaleateActive
Monograph: Chlorpheniramine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.